IVA - Inventiva GAAP EPS of -Euro2.43 revenue of Euro17.48M
2024-03-27 16:06:34 ET
More on Inventiva
- Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause
- Inventiva Phase 2 study for MASH drug meets primary endpoint
- Inventiva resumes Phase 3 study for NASH drug, stock up 6%
- Seeking Alpha’s Quant Rating on Inventiva
- Historical earnings data for Inventiva